These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1728993)

  • 1. Directed immune globulin for the prevention or treatment of neonatal group B streptococcal infections: a review.
    Fischer GW; Weisman LE; Hemming VG
    Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 2):S92-7. PubMed ID: 1728993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of group B streptococcal hyperimmune globulin and standard intravenously administered immune globulin in neonates.
    Weisman LE; Anthony BF; Hemming VG; Fischer GW
    J Pediatr; 1993 Jun; 122(6):929-37. PubMed ID: 8501574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyvalent group B streptococcal immune globulin for intravenous administration: overview.
    Fischer GW; Hemming VG; Gloser HP; Bachmayer H; von Pilar CE; Wilson SR; Baron PA
    Rev Infect Dis; 1990; 12 Suppl 4():S483-9; discussion S489-91. PubMed ID: 2194273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin therapy of neonatal group B streptococcal infections: an overview.
    Fischer GW
    Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S13-6. PubMed ID: 3041355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies in the therapy of experimental neonatal group B streptococcal disease.
    Hill HR; Kelsey DK; Gonzales LA; Raff HV
    Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 2):S87-91. PubMed ID: 1728992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential use of intravenous immune globulin for group B streptococcal infection.
    Baker CJ; Noya FJ
    Rev Infect Dis; 1990; 12 Suppl 4():S476-82. PubMed ID: 2194272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunoglobulins for intravenous use: comparison of available preparations for group B streptococcal antibody levels, opsonic activity, and efficacy in animal models.
    Givner LB
    Pediatrics; 1990 Dec; 86(6):955-62. PubMed ID: 2123536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High intravenous doses of human immune globulin suppress neonatal group B streptococcal immunity in rats.
    Weisman LE; Lorenzetti PM
    J Pediatr; 1989 Sep; 115(3):445-50. PubMed ID: 2671331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous immune globulin therapy for early-onset sepsis in premature neonates.
    Weisman LE; Stoll BJ; Kueser TJ; Rubio TT; Frank CG; Heiman HS; Subramanian KN; Hankins CT; Anthony BF; Cruess DF
    J Pediatr; 1992 Sep; 121(3):434-43. PubMed ID: 1517923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of intravenous immune globulin in newborn infants.
    Fischer GW
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):73-7. PubMed ID: 8033439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characteristics of a modified immunoglobulin preparation for intravenous administration: summary of studies of opsonic and protective activity against group B streptococci.
    Fischer GW; Wilson SR; Hunter KW
    J Clin Immunol; 1982 Apr; 2(2 Suppl):31S-35S. PubMed ID: 7045156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified human immune serum globulin for intravenous administration: in vitro opsonic activity and in vivo protection against group B streptococcal disease in suckling rats.
    Fischer GW; Hunter KW; Wilson SR
    Acta Paediatr Scand; 1982 Jul; 71(4):639-44. PubMed ID: 6753478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative protective activity of human monoclonal and hyperimmune polyclonal antibody against group B streptococci.
    Hill HR; Gonzales LA; Knappe WA; Fischer GW; Kelsey DK; Raff HV
    J Infect Dis; 1991 Apr; 163(4):792-8. PubMed ID: 2010632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The opsonic antibody response of female rats to type III group B streptococcal immunization: a model for maternal immunity.
    Heiman HS; Weisman LE
    Vet Immunol Immunopathol; 1990 Jan; 24(1):79-89. PubMed ID: 2180204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A polyclonal human IgG preparation hyperimmune for type III, group B Streptococcus: in vitro opsonophagocytic activity and efficacy in experimental models.
    Givner LB; Edwards MS; Baker CJ
    J Infect Dis; 1988 Oct; 158(4):724-30. PubMed ID: 3049837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous gamma globulin as adjunct therapy for severe group B streptococcal disease in the newborn.
    Friedman CA; Wender DF; Temple DM; Rawson JE
    Am J Perinatol; 1990 Jan; 7(1):1-4. PubMed ID: 2104748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of intravenous immunoglobulin in neonates.
    Weisman LE; Fischer GW; Marinelli P; Hemming VG; Pierce JR; Golden SM; Peck CC
    Vox Sang; 1989; 57(4):243-8. PubMed ID: 2694604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Obstetric prevention of neonatal infections caused by group B beta-hemolytic Streptococcus].
    Diani F; Turinetto A; Tanganelli E
    Pediatr Med Chir; 1995; 17(4):307-9. PubMed ID: 7491324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous immunoglobulin in neonatal group B streptococcal disease. Pharmacokinetic and safety studies in monkeys and humans.
    Fischer GW; Weisman LB; Hemming VG; London WT; Hunter KW; Bosworth JM; Sever JL; Wilson SR; Curfman BL
    Am J Med; 1984 Mar; 76(3A):117-23. PubMed ID: 6424443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opsonophagocytic Antibodies to Serotype Ia, Ib, and III Group B Streptococcus among Korean Infants and in Intravenous Immunoglobulin Products.
    Kim HW; Lee JH; Cho HK; Lee H; Seo HS; Lee S; Kim KH
    J Korean Med Sci; 2017 May; 32(5):737-743. PubMed ID: 28378545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.